Synthetic biology and precision medicine in blood and gynaecological cancers
David Kerr, Director of Watson for Healthcare in IBM discusses cognitive computing and the difference it will make towards the future of healthcare.
To find out more about the EURECA project go to http://eurecaproject.eu/
Synthetic biology and precision medicine in blood and gynaecological cancers
Early-stage breast cancer detection in breast milk
Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Breast and emerging indications for IORT
The advantages of IORT for early breast cancer treatment
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours